AYTU
Aytu BioPharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.54
-0.10 ▼ -3.79%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$2.54
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -3.84 | Insider Own | 9.46% | Shs Outstand | 0.01B | Perf Week | 0.79% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 81.45% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 11.89% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.57 | Inst Own | 35.14% | Short Float | 4.85% | Perf Quarter | 11.4% |
| Income | -0.02B | P/S | 0.44 | EPS this Y | 45.13% | Inst Trans | 10.63% | Short Ratio | 4.88 | Perf Half Y | 10.43% |
| Sales | 0.06B | P/B | 1.92 | EPS next 5Y | - | ROA | -20.62% | Short Interest | 0.47M | Perf YTD | -2.31% |
| Book/sh | 1.32 | P/C | 0.91 | EPS past 3/5Y | 88.66% 48.61% | ROE | -109.23% | 52W High | -17.13% ($3.07) | Perf Year | 108.2% |
| Cash/sh | 2.8 | P/FCF | - | Sales past 3/5Y | -11.78% 19.16% | ROIC | -97.1% | 52W Low | 167.37% ($0.95) | Perf 3Y | 3.67% |
| Dividend Est. | - | EV/EBITDA | 4.97 | EPS Y/Y TTM | -219.62% | Gross Margin | 62.35% | Volatility(W/M) | 6.68% 5.71% | Perf 5Y | -98.52% |
| Dividend TTM | - | EV/Sales | 0.31 | Sales Y/Y TTM | -8.91% | Oper. Margin | -0.66% | ATR (14) | 0.15 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 1.03 | EPS Q/Q | -301.6% | Profit Margin | -39.02% | RSI (14) | 52.46 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.16 | Sales Q/Q | -6.51% | SMA20 | 3.48% ($2.45) | Beta | 0.31 | Target Price | $9.67 |
| Payout | - | Debt/Eq | 1.56 | Earnings | 2000000 | SMA50 | 0.06% ($2.54) | Rel Volume | 0.25 | Prev Close | $2.64 |
| Employees | 83 | LT Debt/Eq | 0.77 | EPS/Sales Surpr. | -158.18% 24.85% | SMA200 | 10.4% ($2.3) | Avg Volume(3M) | 0.10M | Price | $2.54 |
| IPO | 2008/9/24 | Option/Short | No/Yes | Trades | 915 | Volume | 24,503 | Change | -3.79% |
뉴스 로딩 중...